Introduction
Transarterial N-butyl cyanoacrylate (NBCA)/Onyx embolization, as practiced currently, is performed in most arteriovenous malformations (AVMs). 1 There are those AVMs not amenable to transarterial embolization, usually because of the distal location of the nidus, the small size of the arterial pedicles, or the involvement of associated branches to the adjacent normal brain (Figure 1 ). With continued evolution of microcatheter technology, safe and easy superselective microcatheterization of some pial veins in dural arteriovenous fistulas may be possible. [2] [3] [4] In view of the therapeutic challenges presented by AVMs, transvenous retrograde permeation of an AVM nidus may be possible with a nonpolymerizing liquid embolic material (Onyx), provided that the arterial inflow to the nidus is reduced sufficiently by transarterial NBCA or Onyx embolization, with or without the aid of temporary balloon occlusion of the main arterial feeder. 5 In this study, we reviewed the techniques and their conjunctions and effectiveness.
Methods
This systematic review adopted the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligible related articles were identified by searching the PubMed and Web of Science databases. The combination of search strings that was used in database searches included the terms ''transvenous'' and ''arteriovenous malformation.''
The last literature search was conducted February 9, 2017. All retrieved studies were scanned independently by two reviewers (Lv and Song) to include only AVM patients treated by transvenous approach that had reported their clinical outcomes. We excluded from the final analysis: (a) review studies; (b) peripheral AVMs; (c) experimental articles. Individual-level data available in the papers were collected to be analyzed.
Statistical analyses
All statistical analyses were conducted using SPSS 16.0. We subsequently conducted subgroup analyses according to the rupture and unrupture, AVM locations deep (pontocerebellar, basal ganglia, parisplenic, mesencephalic, hypothalamus, corpus callosum), superficial (parietal, frontal, temporal, insula, Sylvian fissure, cerebellar), AVM nidus size (<3 cm and 3 cm), access vein route (deep or superficial), number of draining veins (single or multiple 2) and Spetzler-Martin grade (SMG) (I-III and IV-V). To determine the factors associated with the complete AVM occlusion and preferable clinical outcome (modified Rankin score (mRS) 0-2), Chi-square test was used. A p < 0.05 was statistically significant.
Results

Study selection
Systematic searches of the PubMed and Web of Science databases yielded 564 and 364 results, respectively. After screening the titles and abstracts, 20 potentially eligible studies for the systematic review were retained. After retrieving the full-text versions of the aforementioned studies, four full texts were excluded ( Figure 2 ). The final 16 search results comprised 60 AVMs in 60 patients analyzed (Table 1 ). [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] 
AVM characteristics and indications
Sixty patients with brain AVMs underwent TRAE procedures; 28 were men, 29 were women and three were not reported. The mean age was 31.8 years (1-64 years). There were 53 (88.3%) ruptured and seven (11.7%) unruptured AVMs, 32 (53.3%) deep location AVMs and 28 (46.7%) superficial location AVMs. According to Spetzler-Martin grade, two (3.3%) were grade I, 12 (20%) grade II, 30 (50%) grade III, 14 (23.4%) grade IV and two (3.3%) grade V. Forty-three (71.7%) AVMs were drained with a single draining vein, 10 (16.7%) were with multiple (two to four) draining veins and the number of draining veins was not reported in seven (11.7%) cases. The mean AVM nidus size was 2.6 cm (0.4 cm to 8 cm). Coexisting aneurysms were reported in three (5%) cases: one anterior inferior cerebellar artery aneurysm, one small thalamostriate artery aneurysm and one anterior choroidal artery aneurysm.
Prior treatment
Prior to TRAE procedure, transarterial Onyx 18 was performed in 23 (38.3%), cyanoacrylate in three (5%) and coiling in two (3.3%), neurosurgery in one (1.7%) and radiosurgery in three (5%). These prior treatments were used to reduce the size of the nidus to <3 cm and TRAE was performed. One anterior choroidal artery aneurysm was coiled before TRAE. 
TRAE procedures
TRAE results and complications
Complete obliteration was achieved in 56 (93.3%) AVMs, four (6.7%) with residual, of which one was supplemented with radiosurgery. The anterior inferior cerebellar artery aneurysm was not treated; it disappeared spontaneously and the small thalamostriate artery aneurysm occluded with nidus. Procedural complications included 10 catheter retained, three hemorrhagic complications (causes were one venous rupture, one venous thrombosis and one not reported) and one brainstem edema caused by venous occlusion. There were no new permanent neurologic deficits after TRAE. 
Statistical analysis
Ruptured AVM and SMG I-III were associated with a higher cure rate, respectively ( Table 2 ).
Discussion
Retrograde intracranial venous catheterization is commonly performed in endovascular treatment of carotidcavernous fistulas, dural arteriovenous fistulas, and vein of Galen malformations, with complete and lasting results. [2] [3] [4] In these lesions, the site of arteriovenous communication is within the leaves of the dura and thus protected from swelling or rupture when the outflow tract is occluded. Before the large AVM feeding arteries are encountered and sacrificed, the vein occlusion will lead to sudden AVM rupture and immediate brain swelling. There are several reports in the literature showing that it is possible to safely microcatheterize pial veins that drain AVMs. 5 Complete permeation of an AVM nidus is possible with Onyx. To consider TRAE, it is necessary to explore further whether this can be performed safely and effectively, requiring an understanding of AVM hemodynamics and, in particular, the probabilities of rupture due to venous occlusion. Changes in systemic blood pressure would be directly conducted to the AVM draining veins. Several methods have been reported to reduce blood flow within an AVM nidus by accomplishing proximal arterial hypotension. 7, 12, 13, 21 This hypotension may be generated at a generalized systemic level or at a local (feeder or intranidal) level. The induction of controlled systemic hypotension (e.g. by using the vasodilators sodium nitroprusside, esmolol, or isoflurane alone or in combination) is a routine technique in cerebrovascular surgical anesthesia and has also been used during transarterial embolization of AVMs. The patient's systolic blood pressure is at least temporarily approximately 20% below normal. Profound hypotension is avoided to minimize the risk of cerebral ischemia. Mean systemic pressure levels of 100 mm Hg are compatible with brain safety and somatosensory evoked potentials are maintained. 7, 12, 20, 21 A local hypotension in relation to a brain AVM can be obtained by temporary balloon occlusion of arterial feeders, and by transarterial NBCA/Onyx embolization that help reduce the flow within an AVM nidus, usually before surgery or radiosurgery. It was found that with clipping of the main feeder of an AVM, the pressure in the draining vein falls from 18 mm Hg to 10 mm Hg (sustained for at least five seconds), with loss of the pulsatile pressure pattern and venous pressure falls to zero at full occlusion of all feeders. 22 Occlusion of the main feeder of an AVM can cause an immediate drop in draining vein pressure. Therefore, temporary systemic hypotension and balloon occlusion of major feeders may provide a practicable way of obtaining the intranidal hypotension that would be desirable for TRAE. A thorough and maximal transarterial NBCA/Onyx embolization might be performed before TRAE not only to occlude the transvenously inaccessible parts of the nidus, but also to yield intranidal reduced blood flow/hypotension that would result in a more efficient retrograde permeation. This would probably be required for larger AVMs, in which the greater nidus volume and feeding arteries need to be reduced by transarterial embolization prior to TRAE.
Previously, jugular access was chosen for the possibility of retaining an undetachable microcatheter. By use of the detachable microcatheters, femoral access was usually chosen and a Navien guiding catheter has increasingly been used. The effect of multiple draining veins was not clear; it seems not to have reduced the cure rate since the use of pre-existing transarterial, neurosurgery or radiosurgery treatment modalities.
TRAE could possibly become an option for the endovascular treatment of selected and anatomically or morphologically favorable AVMs (in relation to both nidus and draining veins) in the following circumstances: small AVMs, especially in cases in which microsurgery or radiosurgery might not be used and/ or endovascular arterial access is difficult or dangerous; and transarterially inaccessible AVM nidus remnants, identifiable by persistent draining vein filling after transarterial embolization or incomplete surgery (which might result in occluded or clipped feeders, preventing access in a subsequent transarterial embolization) or after radiosurgery. There is no evidence that hemodynamic imbalance of AVM was presented with flowrelated aneurysms, intra-nidus aneurysm, varix of venous drainage and peri-nidus edema, 23 because retrograde injection via one draining vein during TRAE would alter the intranidal hemodynamic equilibrium (especially in the presence of feeder and nidus hypotension) to allow retrograde spread of Onyx throughout the nidus. Unlike the case for carotid-cavernous and dural arteriovenous fistulas, there has been a general reluctance to consider TRAE as a treatment of plexiform pial AVMs. If the major venous drainage is interrupted before the arterial feeders are occluded, increased pressure within the nidus can develop into brain edema or catastrophic hemorrhage, because the nidus and its pial veins are not surrounded by a dural envelope. 24, 25 If portions of the nidus and arterial feeders remain patent, then occlusion of the venous outlet can also result in disastrous AVM rupture.
Limitations of this study
A major limitation of this study is the small number of patients due to general lack of quality data and low number of patients. The follow-up is short and this creates an issue for interpreting the long-term outcomes and assessing the rate of rebleeding after treatment. There may be a publication bias in these reports. Procedures that failed because of inability to access the appropriate point for embolization were not reported in previous studies.
Conclusion
According to previous reports, selected AVMs could undergo TRAE. TRAE is safe and curative with Onyx after the nidus size is reduced sufficiently by transarterial embolization, neurosurgery or radiosurgery, with or without the aid of proximal arterial temporary balloon protection.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
